Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Michael Retting"'
Autor:
Keith Stockerl-Goldstein, Liron Shemesh-Darvish, Denise Pereira, John F. DiPersio, Sarah Larson, Nancy M. Hardy, Udo Holtick, Michael Retting, Shaul Kadosh, Giuseppe Milone, Patrick J. Stiff, Irene García-Cadenas, Ella Sorani, Ivana N. Micallef, Gabor Mikala, Douglas W. Sborov, Maria Liz Paciello Coronel, Abi Vainstein, Tahir Latif, Muzaffar H. Qazilbash, Zachary Crees, Massimo Martino, Gemma Moreno Jiménez, John W. Hiemenz, Árpád Illés
Publikováno v:
Blood. 138:2849-2849
Background: CD34+ hematopoietic stem and progenitor cell (HSPC) dose during hematopoietic cell transplantation (HCT) remains one of the most reliable clinical parameters to predict quality of engraftment. A minimum HSPC dose of 2-2.5x10 6 CD34+ cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e430c6b3c970e2560deaf6b241af447e
https://doi.org/10.1182/blood-2021-146783
https://doi.org/10.1182/blood-2021-146783
Autor:
Keith Stockerl-Goldstein, Michael Retting, Liron Shemesh-Darvish, Reyka G Jayasinghe, John F. DiPersio, Abi Vainstein, Shaul Kadosh, Debby Ickowicz, Zachary Crees, Ella Sorani
Publikováno v:
Blood. 138:3816-3816
Background: CD34 expression remains the most common immunophenotypic cell surface marker defining human hematopoietic stem and progenitor cells (HSPCs). Recently, use of multicolor fluorescence-activated cell sorting (mFACS) and single-cell RNA seque
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89ca930e85867d3611ad01f9f9f96f6d
https://doi.org/10.1182/blood-2021-144297
https://doi.org/10.1182/blood-2021-144297
Adverse Outcomes in Acute Myeloid Leukemia Are Associated with Tumor Cell-Mediated Immunosuppression
Autor:
Jacqueline E. Payton, Ann-Kathrin Eisfeld, Ryan B. Day, Bloomfield Clara, Geoffrey L. Uy, Timothy J. Ley, Christopher A. Miller, John S. Welch, Michelle O'Laughlin, Daniel C. Link, Robert S. Fulton, John F. DiPersio, Michael Retting, Keegan A. Christensen, David H. Spencer, Lukas D. Wartman, Nichole M. Helton, Matthew J. Christopher, Peter Westervelt, Matthew J. Schuelke, Sharon Heath, Jessica Kohlschmidt, Francesca Ferraro, Sai Mukund Ramakrishnan, Matthew J. Walter, Jack Baty
Publikováno v:
Blood. 138:800-800
Background: A normal karyotype is the most common cytogenetic finding in acute myeloid leukemia cells ("NK-AML") and has highly variable and difficult to predict outcomes at presentation. Refinements introduced with the ELN 2017 Criteria (presence or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae700ed00e74d4d8c98cbc51f8de11a9
https://doi.org/10.1182/blood-2021-148645
https://doi.org/10.1182/blood-2021-148645